This study aims to answer whether use of a Vcare® intrauterine manipulator leads to an increased incidence of positive peritoneal cytology in patients undergoing surgical management of early stage (FIGO stage I/II) endometrial cancer.
Subjects age 18 or older able to give informed consent
Biopsy diagnosed endometrial cancer (including endometrioid, serous, mucinous and clear cell histologies)
Planned standard of care surgical management of early stage endometrial cancer
No clinical evidence of disseminated intraperitoneal disease
Final pathology does not reflect diagnosis of endometrial cancer (including endometrioid, serous, mucinous, and clear cell histology)
Evidence of disseminated intraperitoneal disease
Subject is not a surgical candidate
Subject elects for fertility sparing or non-operative management
Parallel
surgical staging
Procedure/SurgeryPatients will undergo standard surgical staging for endometrial cancer utilizing either a V-care uterine manipulator or sponge stick
Conversion of positive peritoneal cytology
Intraoperative conversion rate from negative to positive peritoneal cytology will be assessed in each arm
Recurrence rate
Endometrial cancer rates at 2 years from surgery will be assessed
Click on the lead sponsor to view all of their trials.
